Cargando…

Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels

OBJECTIVES: To describe the perinatal outcomes of type II and III selective fetal growth restriction (sFGR) in monochorionic-diamniotic (MCDA) twin pregnancies treated with expectant management or laser ablation of placental vessels (LAPV). METHODS: Retrospective analysis of cases of sFGR that recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyadahira, Mariana Yumi, Brizot, Maria de Lourdes, de Carvalho, Mário Henrique Burlacchini, Biancolin, Sckarlet Ernandes, Machado, Rita de Cássia Alam, Krebs, Vera Lúcia Jornada, Francisco, Rossana Pulcineli Vieira, Peralta, Cleisson Fábio Andrioli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902759/
https://www.ncbi.nlm.nih.gov/pubmed/29723347
http://dx.doi.org/10.6061/clinics/2018/e210
_version_ 1783314810547470336
author Miyadahira, Mariana Yumi
Brizot, Maria de Lourdes
de Carvalho, Mário Henrique Burlacchini
Biancolin, Sckarlet Ernandes
Machado, Rita de Cássia Alam
Krebs, Vera Lúcia Jornada
Francisco, Rossana Pulcineli Vieira
Peralta, Cleisson Fábio Andrioli
author_facet Miyadahira, Mariana Yumi
Brizot, Maria de Lourdes
de Carvalho, Mário Henrique Burlacchini
Biancolin, Sckarlet Ernandes
Machado, Rita de Cássia Alam
Krebs, Vera Lúcia Jornada
Francisco, Rossana Pulcineli Vieira
Peralta, Cleisson Fábio Andrioli
author_sort Miyadahira, Mariana Yumi
collection PubMed
description OBJECTIVES: To describe the perinatal outcomes of type II and III selective fetal growth restriction (sFGR) in monochorionic-diamniotic (MCDA) twin pregnancies treated with expectant management or laser ablation of placental vessels (LAPV). METHODS: Retrospective analysis of cases of sFGR that received expectant management (type II, n=6; type III, n=22) or LAPV (type II, n=30; type III, n=9). The main outcomes were gestational age at delivery and survival rate. RESULTS: The smaller fetus presented an absent/reversed “a” wave in the ductus venosus (arAWDV) in all LAPV cases, while none of the expectant management cases presented arAWDV. The median gestational age at delivery was within the 32nd week for expectant management (type II and III) and for type II LAPV, and the 30(th) week for type III LAPV. The rate of at least one twin alive at hospital discharge was 83.3% and 90.9% for expectant management type II and III, respectively, and 90% and 77.8% for LAPV type II and III, respectively. CONCLUSION: LAPV in type II and III sFGR twins with arAWDV in the smaller fetus seems to yield outcomes similar to those of less severe cases that received expectant management.
format Online
Article
Text
id pubmed-5902759
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-59027592018-04-18 Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels Miyadahira, Mariana Yumi Brizot, Maria de Lourdes de Carvalho, Mário Henrique Burlacchini Biancolin, Sckarlet Ernandes Machado, Rita de Cássia Alam Krebs, Vera Lúcia Jornada Francisco, Rossana Pulcineli Vieira Peralta, Cleisson Fábio Andrioli Clinics (Sao Paulo) Original Article OBJECTIVES: To describe the perinatal outcomes of type II and III selective fetal growth restriction (sFGR) in monochorionic-diamniotic (MCDA) twin pregnancies treated with expectant management or laser ablation of placental vessels (LAPV). METHODS: Retrospective analysis of cases of sFGR that received expectant management (type II, n=6; type III, n=22) or LAPV (type II, n=30; type III, n=9). The main outcomes were gestational age at delivery and survival rate. RESULTS: The smaller fetus presented an absent/reversed “a” wave in the ductus venosus (arAWDV) in all LAPV cases, while none of the expectant management cases presented arAWDV. The median gestational age at delivery was within the 32nd week for expectant management (type II and III) and for type II LAPV, and the 30(th) week for type III LAPV. The rate of at least one twin alive at hospital discharge was 83.3% and 90.9% for expectant management type II and III, respectively, and 90% and 77.8% for LAPV type II and III, respectively. CONCLUSION: LAPV in type II and III sFGR twins with arAWDV in the smaller fetus seems to yield outcomes similar to those of less severe cases that received expectant management. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2018-04-17 2018 /pmc/articles/PMC5902759/ /pubmed/29723347 http://dx.doi.org/10.6061/clinics/2018/e210 Text en Copyright © 2018 CLINICS http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.
spellingShingle Original Article
Miyadahira, Mariana Yumi
Brizot, Maria de Lourdes
de Carvalho, Mário Henrique Burlacchini
Biancolin, Sckarlet Ernandes
Machado, Rita de Cássia Alam
Krebs, Vera Lúcia Jornada
Francisco, Rossana Pulcineli Vieira
Peralta, Cleisson Fábio Andrioli
Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels
title Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels
title_full Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels
title_fullStr Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels
title_full_unstemmed Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels
title_short Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels
title_sort type ii and iii selective fetal growth restriction: perinatal outcomes of expectant management and laser ablation of placental vessels
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902759/
https://www.ncbi.nlm.nih.gov/pubmed/29723347
http://dx.doi.org/10.6061/clinics/2018/e210
work_keys_str_mv AT miyadahiramarianayumi typeiiandiiiselectivefetalgrowthrestrictionperinataloutcomesofexpectantmanagementandlaserablationofplacentalvessels
AT brizotmariadelourdes typeiiandiiiselectivefetalgrowthrestrictionperinataloutcomesofexpectantmanagementandlaserablationofplacentalvessels
AT decarvalhomariohenriqueburlacchini typeiiandiiiselectivefetalgrowthrestrictionperinataloutcomesofexpectantmanagementandlaserablationofplacentalvessels
AT biancolinsckarleternandes typeiiandiiiselectivefetalgrowthrestrictionperinataloutcomesofexpectantmanagementandlaserablationofplacentalvessels
AT machadoritadecassiaalam typeiiandiiiselectivefetalgrowthrestrictionperinataloutcomesofexpectantmanagementandlaserablationofplacentalvessels
AT krebsveraluciajornada typeiiandiiiselectivefetalgrowthrestrictionperinataloutcomesofexpectantmanagementandlaserablationofplacentalvessels
AT franciscorossanapulcinelivieira typeiiandiiiselectivefetalgrowthrestrictionperinataloutcomesofexpectantmanagementandlaserablationofplacentalvessels
AT peraltacleissonfabioandrioli typeiiandiiiselectivefetalgrowthrestrictionperinataloutcomesofexpectantmanagementandlaserablationofplacentalvessels